Castle Biosciences (CSTL) Interest & Investment Income (2018 - 2026)

Castle Biosciences (CSTL) has 9 years of Interest & Investment Income data on file, last reported at $2.5 million in Q1 2026.

• Quarterly Interest & Investment Income fell 17.88% year-over-year to $2.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.2 million (down 13.83% YoY) and the FY2025 annual result came in at $11.8 million, down 8.86% from the prior year.
• Interest & Investment Income eased to $2.5 million in Q1 2026 per CSTL's latest filing, from $2.9 million in the prior quarter.
• The five-year high for Interest & Investment Income was $3.4 million in Q3 2024, with the low at $30000.0 in Q1 2022.
• Average Interest & Investment Income over 5 years is $2.5 million, with a median of $2.8 million recorded in 2025.
• Year-over-year, Interest & Investment Income surged 13282.35% in 2022 and decreased 17.88% in 2026.
• Castle Biosciences' Interest & Investment Income stood at $2.3 million in 2022, then soared by 37.1% to $3.1 million in 2023, then climbed by 8.11% to $3.4 million in 2024, then decreased by 14.12% to $2.9 million in 2025, then slipped by 12.12% to $2.5 million in 2026.
• Business Quant data shows CSTL's Interest & Investment Income at $2.5 million in Q1 2026, $2.9 million in Q4 2025, and $2.8 million in Q3 2025.